Insights

Notes on verification

Occasional, short and practical. Written for finance leadership responsible for U.S. operations, not for the U.S. benefits market.

Note

August 2026

Indirect compensation: what the disclosure does not say

U.S. disclosure rules require broker and consultant compensation to be reported to the plan. The reports are often technically complete and practically uninformative. What a parent company should ask for instead.

Contracts

July 2026

Reading a pharmacy contract for its definitions

Pricing guarantees are meaningful only in relation to how the contract defines a generic, a specialty drug and a rebate. The definitions, not the guarantees, determine the cost.

Stop-loss

June 2026

Attachment points and the claims that never get reimbursed

Late notice, lasering and contract-basis mismatches are the most common reasons a large claim funded by the employer is never recovered from the stop-loss insurer.

Governance

May 2026

What a European board should keep on file

A short list of documents that allow a parent company to demonstrate, years later, why a U.S. healthcare expenditure was approved and on what basis.

Notes are circulated privately to client leadership. To be included, write to us directly.

Before you approve another U.S. healthcare expenditure, know what you're paying for.